Mostafa Adam S.
SEC CIK 1738081 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | CFO | 850.0K | — | $573.2K | 22 | 2021-06-30 | 2025-02-12 |
Most active insiders at XFOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Craig Adam R | Executive COB, Dir | $250.0K | $210.8K |
| 2 | KIRSKE DAVID | CFO | — | $109.2K |
| 3 | Volpone John | Pres | — | $109.2K |
Mostafa Adam S. made no open-market trades at XFOR in the last 12 months.
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | A - Grant | $0.00 | +850.0K | 850.0K | New | $0 | |
| 2025-01-27 | 2025-01-24 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $0.45 | -74.8K | 0 | -100% | -$33.6K | |
| 2025-01-27 | 2025-01-23 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | A - Grant | $0.00 | +74.8K | 74.8K | New | $0 | |
| 2024-10-08 | 2024-10-04 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | A - Grant | $0.00 | +230.6K | 230.6K | New | $0 | |
| 2024-10-08 | 2024-10-07 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $0.55 | -230.6K | 0 | -100% | -$126.9K | |
| 2024-03-11 | 2024-03-11 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $0.88 | -52.5K | 0 | -100% | -$46.2K | |
| 2024-02-12 | 2024-02-12 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $1.01 | -27.7K | 52.5K | -35% | -$28.0K | |
| 2023-11-03 | 2023-11-01 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $0.73 | -230.6K | 80.2K | -74% | -$168.4K | |
| 2023-11-02 | 2023-10-31 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | A - Grant | $0.00 | +230.6K | 310.9K | +288% | $0 | |
| 2023-07-05 | 2023-06-30 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $1.89 | -2,641 | 80.2K | -3% | -$4,991 | |
| 2023-06-26 | 2023-06-23 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $1.93 | -5,417 | 82.9K | -6% | -$10.5K | |
| 2023-06-16 | 2023-06-15 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $2.22 | -5,417 | 88.3K | -6% | -$12.0K | |
| 2023-03-13 | 2023-03-10 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $0.84 | -52.5K | 93.7K | -36% | -$44.1K | |
| 2023-02-15 | 2023-02-13 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $0.93 | -27.7K | 146.2K | -16% | -$25.8K | |
| 2022-08-19 | 2022-08-17 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | — | -10.8K | 173.9K | -6% | — | |
| 2022-07-01 | 2022-06-30 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | — | -2,641 | 184.8K | -1% | — | |
| 2022-06-27 | 2022-06-24 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | — | -5,416 | 187.4K | -3% | — | |
| 2022-06-17 | 2022-06-16 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | — | -5,416 | 192.8K | -3% | — | |
| 2022-03-01 | 2022-03-01 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | A - Grant | $0.00 | +105.0K | 198.2K | +113% | $0 | |
| 2022-02-14 | 2022-02-11 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | — | -27.7K | 93.2K | -23% | — | |
| 2021-08-19 | 2021-08-17 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $5.10 | -10.8K | 120.9K | -8% | -$55.2K | |
| 2021-07-01 | 2021-06-30 | XFOR | X4 Pharmaceuticals, Inc | Mostafa Adam S. | CFO | S - Sale | $6.64 | -2,641 | 131.8K | -2% | -$17.5K |
Purchase Sale Sale after option exercise All abbreviations